Copernicus Capital Management, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.

Quarter-by-quarter ownership
Copernicus Capital Management, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$337,000
+10.9%
7,000
+19.7%
5.44%
+14.9%
Q4 2020$304,000
-88.0%
5,847
-93.8%
4.74%
+95.7%
Q3 2020$2,542,00095,0002.42%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
BRIDGER MANAGEMENT, LLC 1,647,000$6,423,0000.45%
DAFNA Capital Management LLC 75,000$293,0000.30%
Baker Brothers Advisors 2,199,656$8,579,0000.12%
STONERIDGE INVESTMENT PARTNERS LLC 71,105$277,0000.05%
SMITH ASSET MANAGEMENT GROUP LP 196,684$767,0000.03%
SABBY MANAGEMENT, LLC 66,000$257,0000.02%
THOMPSON DAVIS & CO., INC. 1,000$4,0000.01%
COLUMBUS CIRCLE INVESTORS 161,919$631,0000.00%
JENNISON ASSOCIATES LLC 455,271$1,776,0000.00%
BlackRock Fund Advisors 448,445$1,749,0000.00%
View complete list of TG THERAPEUTICS INC shareholders